PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 32 filers reported holding PROQR THRAPEUTICS N V in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $224,000 | -5.1% | 72,796 | -0.4% | 0.00% | – |
| Q4 2017 | $236,000 | -40.3% | 73,096 | -10.3% | 0.00% | – |
| Q3 2017 | $395,000 | -0.8% | 81,494 | +6.5% | 0.00% | – |
| Q2 2017 | $398,000 | +4.2% | 76,494 | 0.0% | 0.00% | – |
| Q1 2017 | $382,000 | +1.9% | 76,494 | 0.0% | 0.00% | – |
| Q4 2016 | $375,000 | -26.5% | 76,494 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $510,000 | +37.8% | 76,494 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $370,000 | -3.1% | 76,494 | -2.3% | 0.00% | 0.0% |
| Q1 2016 | $382,000 | -43.8% | 78,294 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $680,000 | -43.9% | 78,294 | -6.0% | 0.00% | -50.0% |
| Q3 2015 | $1,213,000 | -10.9% | 83,250 | +2.0% | 0.00% | 0.0% |
| Q2 2015 | $1,361,000 | -18.0% | 81,640 | +7.7% | 0.00% | 0.0% |
| Q1 2015 | $1,659,000 | +1.5% | 75,800 | +0.5% | 0.00% | -33.3% |
| Q4 2014 | $1,634,000 | – | 75,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Privium Fund Management B.V. | 5,344,446 | $18,010,783 | 6.83% |
| M28 Capital Management LP | 1,910,600 | $7,069,220 | 6.74% |
| Opaleye Management Inc. | 1,460,000 | $5,402,000 | 1.88% |
| Ikarian Capital, LLC | 422,625 | $1,563,713 | 0.38% |
| Monaco Asset Management SAM | 165,000 | $610,500 | 0.18% |
| AWM Investment Company, Inc. | 166,667 | $616,668 | 0.09% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $555 | 0.05% |
| Atom Investors LP | 18,522 | $68,531 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $13,414,228 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 21,514 | $80 | 0.01% |